Tonix Pharmaceuticals
TNXP
#8883
Rank
C$0.27 B
Marketcap
C$17.52
Share price
-0.80%
Change (1 day)
-63.70%
Change (1 year)

Earnings for Tonix Pharmaceuticals (TNXP)

Earnings in 2025 (TTM): -C$0.14 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current earnings are C$10.29 Million. In 2024 the company made an earning of -C$0.11 Billion, an increase over its 2023 earnings that were of -C$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tonix Pharmaceuticals from 2008 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.14 Billion25.88%
2024 -C$0.11 Billion-36.5%
2023 -C$0.17 Billion5.61%
2022 -C$0.16 Billion21.43%
2021 -C$0.14 Billion82.76%
2020 -C$71.72 Million75.22%
2019 -C$40.93 Million9.52%
2018 -C$37.38 Million23.63%
2017 -C$30.23 Million-45.36%
2016 -C$55.33 Million-19.09%
2015 -C$68.39 Million74.15%
2014 -C$39.27 Million153.99%
2013 -C$15.46 Million
2011 -C$7.46 Million29538.74%
2010 -C$0.03 Million-42.58%
2009 -C$0.05 Million46.05%
2008 -C$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-C$33 Million-75.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
C$50.62 M-137.16%๐Ÿ‡บ๐Ÿ‡ธ USA